The economics of prevention in the BRCA mutation carrier: Epithelial ovarian cancer (EOC) prevention by risk-reducing surgery (RRS) is cost effective compared to treatment upon cancer development
- Resource Type
- Abstract
- Source
- In
Gynecologic Oncology June 2018 149 Supplement 1:242-243 - Subject
- Language
- ISSN
- 0090-8258